Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Prader-Willi Syndrome Forecast in 9 Major Markets Report 2016-2026 - Analysis, Technologies & Forecasts - Research and Markets

Research and Markets
Posted on: 13 Sep 16

Research and Markets has announced the addition of the "Prader-Willi Syndrome Forecast in 9 Major Markets 2016-2026" report to their offering.

This report provides the current prevalent population for Prader-Willi disease across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Several of the main symptoms and co-morbidities of Prader-Willi disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Prader-Willi disease include:

  • Cardiovascular Problems
  • Obstructive sleep apnoea and respiratory disorders
  • Diabetes Type II
  • Autism Spectrum Disorder Behavioural Characteristics
  • Seizures
  • Hip dysplasia
  • Scoliosis

Reason to Buy:

  • Able to quantify patient populations in global Prader-Willi disease's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Prader-Willi disease and identify patient segments with high potential.
  • Identify sub-populations within Prader-Willi disease which require treatment.
  • Gain an understanding of the specific markets that have the largest number Prader-Willi disease patients.

Report Structure:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key Co-morbid Conditions/ Features Associated with the Disease

8. Methodology for Quantification of Patient Numbers

9. Top-Line Prevalence for Prader-Willi Syndrome

10. Main Complications and Features of Prader-Willi Patients

11. Abbreviations used in the Report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

15. Appendix

For more information about this report visit

Related Topics: Pharmaceuticals

View source version on

Business Wire

Last updated on: 13/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.